Evidence map›Paper›PMID 36853051›Full record

ArticlemSphere2023

Homologues of the Chlamydia trachomatis and Chlamydia muridarum Inclusion Membrane Protein IncS Are Interchangeable for Early Development but Not for Inclusion Stability in the Late Developmental Cycle.

María Eugenia Cortina, Isabelle Derré

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Split-GFP Reporter-Based Detection of Chlamydia trachomatis Inclusion Damage.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Inclusion Membrane Proteins ofMicroorganisms · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. mBio · 2024
    Article
  9. Review
  10. Type III Secretion inMicrobiology and molecular biology reviews : MMBR · 2023
    Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

María Eugenia CortinaDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Isabelle DerréDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0002-7055-4346
University of Virginia · US

Funding

Host-pathogen interactions controlling Chlamydia developmental cycleR01AI162758 · NIAID · UNIVERSITY OF VIRGINIA · PI DERRE, ISABELLE · 2021 to 2025
$1.9M
Regulation and composition of ER-inclusion contacts at key stages of the Chlamydia developmental cycleR21AI166237 · NIAID · UNIVERSITY OF VIRGINIA · PI DERRE, ISABELLE · 2022 to 2023
$425k
NIAID NIH HHS AI162758NIAID NIH HHS AI166237NIAID NIH HHS R01 AI162758NIAID NIH HHS R21 AI166237
6 · The paper itself

Abstract

Chlamydia trachomatis is an obligate intracellular bacterium, which undergoes a biphasic developmental cycle inside a vacuole termed the inclusion. Chlamydia-specific effector proteins embedded into the inclusion membrane, the Inc proteins, facilitate inclusion interaction with cellular organelles. A subset of Inc proteins engages with specific host factors at the endoplasmic reticulum (ER)-inclusion membrane contact site (MCS), which is a discrete point of contact between the inclusion membrane and the endoplasmic reticulum (ER). Here, we report that the C. trachomatis Inc protein CTL0402/IncS

Indexed as

Chlamydia muridarumChlamydia trachomatisAnimalsBacterial ProteinsEndoplasmic ReticulumHumansMembrane ProteinsMiceBacterial ProteinsMembrane ProteinsChlamydia developmental cycleChlamydia genome editingChlamydia muridarumChlamydia trachomatiseffector proteinsER-inclusion membrane contact sitesFRAEM/FLAEMinclusion membrane proteinsIncS/CTL0402/TC0424species specificitySTIM1temporal mutant complementation

Identifiers

PMID36853051
PMCPMC10117133
OpenAlexW4322617223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.